Patent · US Active

Anti-mycobacterial drugs against tuberculosis

US9650360B2 · kind B2 · utility

0Cited by

4References

33Claims

0Family size

Assignee

University of Georgia Research Foundation, Inc. · US

Inventors

Vasu Nair · Athens, US
Maurice O. Okello · Athens, US
Machhindra G. Gund · Athens, US
Byung I. Seo · Athens, US
Pankajkumar R. Singh · Saputara, IN
Naveen K. Mangu · Athens, US

Key dates

Filing date	Mar 13, 2013
Grant date	May 16, 2017
Priority date	—
Expiry date	Apr 16, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D213/64
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the field of anti-mycobacterial therapeutics, in particular the treatment of tuberculosis, especially including pulmonary multidrug-resistant tuberculosis (MDR-TB), with applications in extensively drug-resistant tuberculosis (XDR-TB) and extremely drug-resistant tuberculosis (XXDR-TB), preferably in combination therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.